3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
2
Terminated
2
Recruiting
2
Enrolling by invitation
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gynecologic
2
Conditions
Uterine Cervical Neoplasms
2
Uterine Cervical Dysplasia
1
Interventions
Cisplatin
18
pembrolizumab
12
Paclitaxel
9
Carboplatin
9
Radiotherapy
5
Gemcitabine
4
Fluorodeoxyglucose F18
4
Colposcopy
4
Brachytherapy
4
fludarabine
3
durvalumab
3
Surveys and Questionnaires
3
Radiation
3
Flow Cytometry
3
Cyclophosphamide
3
Biopsy
3
Bevacizumab
3
toripalimab
2
fludarabine phosphate
2
atezolizumab
2
aldesleukin
2
adavosertib
2
Zoledronic Acid
2
Topotecan
2
Nivolumab
2
Neoadjuvant Therapy
2
Microarray Analysis
2
Magnetic Resonance Spectroscopy
2
Interviews as Topic
2
Interleukin-2
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
Uterine Cervical Neoplasms
×
Conization
×
Clear all
NCT06752135
2024-12-30
HRCC1
Azienda Policlinico Umberto I
Terminated
97 enrolled
NCT03852979
2020-01-10
NEOCON-F
The Netherlands Cancer Institute
Phase 2
Terminated
1 enrolled